The QualityStocks Daily Monday, March 1st, 2021

Today's Top 3 Investment Newsletters

Schaeffer's(MORF) +134.65%

QualityStocks(HUML) +71.88%

InvestorBrandNetwork(SHRG) +56.35%

The QualityStocks Daily Stock List

Genius Brands International Inc. (NASDAQ: GNUS) (FRA: 4XV)

QualityStocks, InvestorPlace, RedChip, StocksEarning, TraderPower, PennyStockNewsletter.info, StockMarketWatch, StockOrange, Schaeffer's, MarketBeat, Market Intelligence Center Alert, TradersPro, PennyStocks24, StreetInsider, Kiplinger Today, Beacon Equity Research, BUYINS.NET, Trades Of The Day, MicroStockProfit, Penny Stocks Finder, Stock Preacher, TopPennyStockMovers, MarketClub Analysis, Trading Concepts, Stock Roach, The Momentum Traders Network, Greenbackers, Financial News Media, Corporate Profile Media, The Street, Timothy Sykes, Barchart and AllPennyStocks reported earlier on Genius Brands International Inc. (GNUS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Genius Brands International Inc. (NASDAQ: GNUS) (FRA: 4XV) is a brand and content management company that operates as a children’s media company. The firm develops and licenses media content for infants and young children across the globe.

The firm was established in 2006 and changed its name from Pacific Entertainment Corporation to Genius Brands International Inc. in 2011. The company’s headquarters are in Beverly Hills, California and it serves various partners and consumers including retailers, wholesalers, broadcasters, manufacturers and consumer products licensees.

Genius Brands International’s products are targeted to educate and entertain toddlers and young children. The firm is engaged in the production, marketing and licensing of kids’ entertainment properties and consumer products for retail and media distribution such as book products, CD music and DVDs.

The Genius Brands International portfolio includes the new preschool show, toddler brand Baby Genius, Thomas Edison’s Secret Lab, which is a STEM-based adventure and comedy series, Warren Buffett’s Secret Millionaires Club, which is an animated series for children, Netflix’s Llama Llama, Nick Jr.’s Rainbow Rangers which entails the adventures of 7 magical girls and SpacePop, a fashion and music driven animated property. In addition to this, the firm acts as Llama Llama’s licensing agent. Genius Brands International’s channel is available on both mobile devices and television via distribution platforms such as Amazon Fire, Comcast, Roku, Cox, Apple TV, Sling TV and DISH.

The company recently debuted a preview for Stan Lee’s Superhero Kindergarten, with Arnold Schwarzenegger as a leading voice role. Stan Lee was one of the most prolific writers of the Marvel Cinematic Universe and if we know anything about Lee, is that it’s bound to be good. Good ratings and even better earnings may be witnessed, so keep a close watch on the firm’s stocks.

Genius Brands International Inc. (GNUS), closed Monday's trading session at $1.695, off by 0.294118%, on 9,944,560 volume with 27,560 trades. The average volume for the last 3 months is 29,673,706 and the stock's 52-week low/high is $0.051600001/$11.7299995.

Meten EdtechX Education Group Ltd. (NASDAQ: METX)

MarketClub Analysis and INO Market Report reported earlier on Meten EdtechX Education Group Ltd. (METX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Meten EdtechX Education Group Ltd (NASDAQ: METX) is an English Language Training service provider which offers English language and future skills training for Chinese professionals and students. The firm offers its services through a nationwide network of learning centers as well as a digital platform.

Meten EdtechX Education Group Ltd was established in 2006 and has its headquarters in Shenzhen, China. The firm operates through 4 segments, i.e. Junior English Training, Overseas Training Services, Online English Training, and General Adult English Training.

Meten EdtechX Education Group’s objective is to improve the overall English language competitiveness and competence of the Chinese population, in an attempt to keep up with the globalization’s rapid development.

The firm offers its services under the following brand names: Likeshuo, which offers online English language training services, ABC which is mostly comprised of junior English Language Training services, and Meten which offers junior and adult ELT services. Meten EdtechX uses A1-driven centralized management and teaching systems across its business, which analyze and record learning processes in the present time thus providing superior teaching quality and student satisfaction.

Meten EdtechX Group Ltd has 149 learning centers distributed in 36 cities covering 18 provinces in China. With a total addressable market of more than 600 cities in China and forecasts showing that the urban population in China will reach one billion in less than a decade, Meten EdtechX Group Ltd is in for significant growth in the years to come, especially if one factors in the increasing demand for bilingual talents and the growing numbers of students who are studying abroad.

Meten EdtechX Education Group Ltd. (METX), closed Monday's trading session at $2.35, off by 1.2605%, on 1,409,840 volume with 3,842 trades. The average volume for the last 3 months is 3,754,840 and the stock's 52-week low/high is $1.70969998/$23.7499008.

Sensus Healthcare Inc. (NASDAQ: SRTS) (FRA: 5TX)

MarketBeat, TraderPower, StockMarketWatch, Trades Of The Day, StreetInsider, MarketClub Analysis and Daily Trade Alert reported previously on Sensus Healthcare Inc. (SRTS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Sensus Healthcare Inc. (NASDAQ: SRTS) (FRA: 5TX) is a medical device firm that develops cost-effective, minimally invasive as well as non-invasive treatments for both non-oncological and oncological skin conditions, which have been proven to be highly effective.

Sensus Healthcare Inc. was founded by Stephen Cohen, Richard Golin, Kalman Gishman and Joseph C. Sardano in May 2010 and is based in Boca Raton, Florida. The company is a part of the Medical Equipment and Supplies Manufacturing Industry and serves consumers from all over the world. Sensus Healthcare Inc.’s revenue is generated primarily in the United States.

The company uses a low-energy X-ray technology termed as SRT (superficial radiation therapy), which it incorporated into its treatment device portfolio. The devices include the SRT-100 Vision, the SRT-100+ and the SRT-100. Its superficial radiotherapy system is used by dermatologists and oncologists to offer patients who opt out of surgery an alternative way to treat squamous cell and basal cell skin cancer, as well as other skin conditions, like keloids. Sensus Healthcare Inc. also provides a professional skin care line, known as Sensus Skin Solutions.

Sensus Healthcare Inc. recently introduced its ScultpturaTM robotic radiation oncology system which offers brachytherapy and triple-modulated intraoperative radiotherapy to treat patients who are going through treatment for cancer in surgery or at the site of the tumor in an efficient and fast way.

The firm recently received a patent for its Sculptura system, which will allow for more ways to deliver radiation to treat all types of solid tumors. Sensus Healthcare Inc. enhances the quality of life of patients across the globe and with its latest design, may make it easier to treat cancerous tumors, which makes the potential demand of the product pretty high.

Sensus Healthcare Inc. (SRTS), closed Monday's trading session at $4.94, up 8.0963%, on 1,345,414 volume with 6,520 trades. The average volume for the last 3 months is 479,247 and the stock's 52-week low/high is $1.76030004/$6.09000015.

VBI Vaccines Inc. (NASDAQ: VBIV) (FRA: LO91)

NasdaqReport, MarketBeat, StockMarketWatch, TopNasdaqStocks, InvestorPlace, BUYINS.NET, Schaeffer's, TradersPro, StreetInsider, The Street, InvestorsUnderground, MarketClub Analysis, Stock News Now, Wealth Insider Alert, The Online Investor, Marketbeat.com, DreamTeamNetwork and Daily Trade Alert reported beforehand on VBI Vaccines Inc. (VBIV), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

VBI Vaccines Inc. (NASDAQ: VBIV) (FRA: LO91) is a biopharmaceutical firm that develops and sells vaccines for the treatment of immune-oncology and infectious ailments.

VBI Vaccines Inc. was known as SciVac Therapeutics Inc. before changing its name to VBI Vaccines Inc. in May 2016. The firm is based in Cambridge, Massachusetts and operates in Canada, Israel, the United States as well as internationally. VBI Vaccines Inc. is engaged in the development of vaccine products and platforms for licensing to biotech companies and pharmaceutical firms.

The firm, which mostly serves pharmacists and physicians through direct sales, also has license and collaboration agreements with GlaxoSmithKline Biologicals S.A. and Brii Biosciences Ltd. This is in addition to a Syneos Health Inc. partnership for the commercialization of the firm’s Sci-B-Vac prophylactic hepatitis B vaccine in Canada, Europe and the U.S., which is yet to be approved, as well as a collaboration with Canada’s National Research Council for the development of a pan-covid-19 vaccine candidate which targets the Middle East respiratory syndrome, severe acute respiratory syndrome and the coronavirus.

VBI Vaccines provides a vaccine platform which allows for the development of enveloped virus-like particle vaccines which imitate a target virus, thereby bringing about a potent immune response. The firm’s portfolio includes VBI-2601, an immunotherapeutic indicated for the cure of chronic hepatitis B and VBI-1901, an immunotherapeutic glioblastoma vaccine candidate, which is currently undergoing phase 1/2a clinical study.

The firm recently announced FDA acceptance of BLA filing for its Sci-B-Vac prophylactic hepatitis B vaccine, which will prevent the infection that is caused by hepatitis B subtypes in adults. Hepatitis B is an infectious ailment that has infected more than 290 million individuals across the globe, with the HBV being the leading cause of liver disease. Every year, roughly 780,000 individuals succumb to complications of chronic HBV. A treatment for this condition would therefore be widely welcomed.

VBI Vaccines Inc. (VBIV), closed Monday's trading session at $3.62, up 7.4184%, on 4,279,749 volume with 13,110 trades. The average volume for the last 3 months is 7,628,289 and the stock's 52-week low/high is $0.689999997/$6.92999982.

Bushveld Minerals Limited (BSHVF)

We reported earlier on Bushveld Minerals Limited (BSHVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets, Bushveld Minerals Limited is a low-cost, vertically integrated primary vanadium producer. The Company owns a varied vanadium product portfolio serving the needs of the steel, energy, as well as chemical sectors. Bushveld Minerals participates in the entire vanadium value chain via its two primary pillars. One is Bushveld Vanadium, which mines and processes vanadium. The other is Bushveld Energy, an energy storage component manufacturer and project developer, centered on vanadium-based energy storage systems called Vanadium Redox Flow Batteries (VRFBs). Bushveld Minerals has its corporate headquarters in Illovo, Johannesburg, South Africa.

The Company is one of only three operating primary vanadium producers, owning two of the globe’s four operating primary vanadium processing facilities, presently producing about 3,000 metric tonnes of Vanadium per annum (mtVp.a.). This represents roughly 3 percent of the worldwide vanadium market. Bushveld Minerals’ target is to organically grow production to greater than 8,400 mtVp.a. in the medium term.

Via Vametco and Vanchem, Bushveld Minerals produces Nitrovan, ferrovanadium, vanadium oxides, and vanadium chemicals. This produces a diversified revenue stream from the steel, chemicals, and energy storage markets.

Recently, Bushveld Minerals told investors that the ramp-up of operations following the coronavirus (COVID-19) pandemic lockdown has continued. The Company expects annual group production to be up by 25 percent-35 percent versus 2019. Nonetheless, it added that it won’t catch-up the volumes missed out on during lockdown, because of changes to allow social distancing, and as a result, the full-year production tally will be at the lower end of previous guidance.

Bushveld Minerals Limited (BSHVF), closed Monday's trading session at $0.35, up 27.7372%, on 27,700 volume with 7 trades. The average volume for the last 3 months is 44,279 and the stock's 52-week low/high is $0.000099999/$0.600000023.

Potash America, Inc. (PTAM)

QualityStocks, PennyStockLocks.com, StockRockandRoll, StockLockandLoad, StockBomb.com, AnotherWinningTrade, ChartAdvisor, FeedBlitz, Insider Wealth Alert, InvestmentHouse, MajorPennyStocks, Market FN, OTCPicks, Penny Stock Circle, Penny Stock Pros, PennyStockClub, 1-2-3 Stock Alerts, PennyTrader Publisher, Wyatt Investment Research, Real Pennies, Stock Research Newsletter, StockMarketQuote.us, The Best Newsletters, The Stock Enthusiast, The Stock Scout, The Trading Report and PennyStockProfessor reported  previously on Potash America, Inc. (PTAM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Potash America, Inc. is a multi-stage investment group listed on the OTC Markets. The Company pursues compelling technology, product, as well as service opportunities in innovative, emerging, and growing markets. The Company was previously known as Adtomize, Inc. It changed its name to Potash America, Inc. in March of 2011. Formed in 2007, Potash America has its corporate headquarters in Boca Raton, Florida.

The Company partners with inventive entrepreneurs in venture and growth capital investments. Potash America’s investment vision continues to explore the Environmentally Responsible Mining & Exploration, Renewable Energy, Commercial Agriculture Farming, Cannabis/Hemp Development, Health & Wellness, and Green Technology sectors.

Potash America pursues a strategy named “high-fusion.” With this approach, high-risk/high-reward ventures are balanced by more traditionally stable companies. This establishes a more varied portfolio that enables the Company to invest in creative or unempirical entrepreneurships whose partnerships it otherwise could not pursue.

Potash America plays a part in its potential partners’ growth beyond initial capital investment. To provide consistent support to its portfolio companies, the Company pursues several avenues to help them realize their goals. It is able to play a part in their growth via locating and negotiating acquisitions, financial remodeling, negotiating key strategic agreements, and raising capital.

Key sectors of Potash America’s portfolio include socioeconomic/environmentally responsible mining & exploration, renewable energy, and commercial agriculture farming. In addition, key sectors of its portfolio include cannabis and hemp development, health & wellness, and green technology. At present, mining & exploration includes investment opportunities in surface mining (open pit, dredging, placer, strip, hydraulic and mountain top) and underground mining (drift, hard rock, shaft, and slope).

Pertaining to renewable energy, Potash America chiefly dedicates its investment opportunities to solar, wind, biomass, and hydroelectric energy. Nonetheless, the Company maintains an interest in geothermal, hydrogen, as well as fuel cells. Moreover, regarding health & wellness, Potash America is looking to partner with creative entrepreneurs advancing new products in the health & wellness space, offering capital investment and guidance.

Potash America, Inc. (PTAM), closed Monday's trading session at $0.023, up 31.4286%, on 1,602,895 volume with 57 trades. The average volume for the last 3 months is 446,645 and the stock's 52-week low/high is $0.004999999/$0.026.

CarSmartt, Inc. (CRSM)

QualityStocks and Small Cap Firm reported previously on CarSmartt, Inc. (CRSM), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

CarSmartt, Inc. is an American transportation network company (TNC) offering a peer-to-peer ridesharing service. Its platform can be accessed through its mobile app (Android and iOS). The Company formerly went by the name Sports Supplement Group, Inc. It changed its corporate name to CarSmartt®, Inc. in February of 2018. The Company serves markets in the Southeast region of the United States. CarSmartt has its head office in Coral Gables, Florida. The Company lists on the OTC Markets.

All CarSmartt drivers are subject to background checks to reassure the safety of the Company’s passengers. CarSmartt’s application is made to connect drivers with the world's travelers to make long-distance trips affordable. CarSmartt provides ridesharing services to users via their App at app.carsmartt.com.

CarSmartt’s mission is to democratize mobility and create a liberated ecosystem for road transportation. This means being more economic for drivers, and also efficient, transparent, eco-friendly, and higher earnings for drivers.

CarSmartt previously announced its Carsmartt App (iOS and Android). The platform has many features that enable CarSmartt's drivers to earn more money and allow riders to save more on fares.

Every driver who wants to work with CarSmartt needs to log in to the GoodHire site and submit their information by way of a link that will be posted on the Company’s website. This ensures third party verification of CarSmartt drivers and increases the level of security considerably.

Recently, CarSmartt announced its user growth and its start of development on its new "YouSmartt" service. YouSmartt will provide, for all CarSmartt participants, access to a proprietary network of up to 45 discounted ancillary offerings. This will include, but is not limited to, the areas of Beauty, Home Care, Auto Care, Pet Care, Child Care, Personal Care, Education, Technology Services, Entertainment, Travel, and Leisure.

CarSmartt, Inc. (CRSM), closed Monday's trading session at $0.0126, up 34.0426%, on 2,136,753 volume with 68 trades. The average volume for the last 3 months is 2,543,738 and the stock's 52-week low/high is $0.004699999/$0.039999999.

Beliss Corp. (BLIS)

QualityStocks, Small Cap Firm, StockRockandRoll, Shiznit Stocks, ProTrader, PennyStockLocks, Penny Stock Titans, Penny Stock General, Penny Stock 101, MassiveStockProfits and GrowthPennyStocks reported previously on Beliss Corp. (BLIS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Beliss Corp. has entered into preliminary agreements for valuable shipwreck treasure recovery opportunities, sites, projects and persons. The Company will be changing it’s name to Treasure & Shipwreck Recovery, Inc. It concentrates on the discovery and recovery of valuable artifacts and treasure from researched sites and shipwrecks. It will conduct shipwreck and treasure recovery from shallow shipwreck finds in the Caribbean and North America, as found previously. Beliss Corp. is headquartered in St. Petersburg, Florida.

Beliss’ intention is to expand into media projects for other matters in games, television and sales of artifacts. The Company has its own and partnered vessels to use on its numerous shipwreck sites.

Beliss’ main emphasis will be on ancient cargo wrecks (prior to 1800 wrecks), including galleons transporting gold, silver and jewels from the new world to Europe. Nonetheless, the Company will also target proven and claimed areas for more modern 19th century wrecks. These can contain very valuable and unique cargoes, such as rare intricate artifacts, jewelry, furnishings, arms, coinage, as well as other items. The first primary site is at Cape Romain, South Carolina.

Beliss will first do the Florida coastal survey on the way to the large South Carolina claim area with multiple shipwrecks on a large admiralty claim contracted with the Chairman, Dr. Spence, who owns the admiralty claim that has dozens of unexplored wrecks. Three Wrecks have been initially worked and will be worked, which have continually yielded valuable artifacts, on a continuing basis. Dozens of others will be surveyed at that location. All expeditions will be filmed for publicity, and for future television rights and production by partners in the industry.

Recently, Beliss (Treasure & Shipwreck Recovery, Inc.) announced that it entered into a purchase agreement to acquire the data and coordinates from shipwreck scans and technical mapping encompassing up to 60-mile-long areas off the east coast of Florida. The information will be used by crews in the immediate future for exploration and expected shipwreck recoveries.

The Company also previously announced that it successfully recovered artifacts from its initial dives on the earlier scanned areas. This includes what is believed to be the boundaries of a suspected 17th century shipwreck. Among items identified was a cannon from the period and an anchor, which was recovered, along with other items. Beliss used the recently announced purchased data to make the finds on initial dives.

The Company announced that it posted to YouTube.com a video of the cannon recently found off the east coast of Florida. Research suggests the cannon and anchor found are likely from the same 17th century shipwreck. The video can be viewed at https://youtu.be/pPqghpKjgJM.

Beliss Corp. (BLIS), closed Monday's trading session at $0.22, up 44.7368%, on 11,100 volume with 5 trades. The average volume for the last 3 months is 3,502 and the stock's 52-week low/high is $0.035/$0.75.

Humble Energy, Inc. (HUML)

We reported previously on Humble Energy, Inc. (HUML), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

Humble Energy, Inc. is an oil and gas production and exploration company listed on the OTC Markets. Natural gas is 85 percent of the Company’s production. Humble Energy also owns coal minerals. It owns coal minerals in fee simple title that are high BTU metallurgical quality coal. Additionally, Humble has Coking coal with a high Button nine plus that blends with lesser coals to make steel. Humble Energy has its head office in Paron, Arkansas.

It commenced operations as a private Texas Corporation in 1999 as Humble Petroleum, Inc. In May 2009, Humble Petroleum, Inc. bought Humble Energy, Inc. transferring ownership interests in 83 wells in Texas, Wyoming, New Mexico, Kansas and Oklahoma. The wells purchased 85 percent of the common stock in Humble Energy, Inc. On December 30, 2013, Humble Petroleum, Inc. transferred the remaining assets of Humble Petroleum, Inc. that included oil and natural gas wells, coal, ATTI, and Power Klean. Humble Petroleum, Inc. common shares became Humble Energy, Inc. shares.

Currently, Humble Energy is participating in drilling 10 wells in the prolific Cotton Valley sand formation in Louisiana. The first 9 horizontal wells came in at 108,000,000 cubic feet per day on a 44/64 choke. Because of the successful results of the first 9 wells Humble has agreed to participate in the drilling of 4 more Cotton Valley formation wells.

Furthermore, the Company is participating in the drilling of 7 more wells in the Haynesville shale formation. Twenty more total wells will be drilled. Moreover, Humble has participated in drilling and completing producing horizontal wells in Kingfisher County, Oklahoma. The Company states that production to date has been excellent.

Humble Energy has its Power Klean product. Power Klean cleanses out contaminated motor oil. Tests show that the system removes greater than 85 percent of the harmful contaminates, wear metals, and carbon that typical oil changes miss. Features of Power Clean include lessening friction; extending engine life; increasing horsepower, and improving gas mileage. In addition, features include keeping oil cleaner for higher performance oil changes.

Humble Energy, Inc. (HUML), closed Monday's trading session at $3.85, up 71.875%, on 226,766 volume with 1,039 trades. The average volume for the last 3 months is 32,778 and the stock's 52-week low/high is $0.119999997/$7.9499998.

Acro Biomedical Co., Ltd. (ACBM)

We reported beforehand on Acro Biomedical Co., Ltd. (ACBM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Acro Biomedical Co., Ltd. focuses on developing and marketing products that promote wellness and a healthy lifestyle. Its intention is to conduct research and development (R&D) on its own proprietary products based on cordyceps sinensis. The Company previously went by the name Killer Waves Hawaii, Inc. It changed its name to Acro Biomedical Co., Ltd. in January of 2017. Acro Biomedical is based in Fishers, Indiana.

Cordyceps sinensis has been described as a medicine in old Chinese medical books and Tibetan medicine. Cordyceps sinensis is a rare combination of a caterpillar and a fungus. It is found at altitudes above 4500m in Sikkim. Acro Biomedical originated from a group of scholars at the University of Taiwan. The Founder, Mr. Richard Chu, was looking for the materials for disease treatment and health care from traditional Chinese medicine and natural herbal medicine. The preferred material is China treasure, "Cordyceps".

The Company will operate in two main areas. These are health food development and new drug development. The first decade of Acro Biomedical was the development of scientific research to establish a combination of basic science. Since the founding of the Company, the target has always been scientific applications and market development.

The objective of establishing a technology and market integration business model centers on diverse areas. These include China, Southeast Asia, Northeast Asian, Central Asian and the Europe and United States market. Moreover, there are two special markets, one for the Chinese health industry market and one for the longevity of health care market.

Acro Biomedical Co., Ltd. (ACBM), closed Monday's trading session at $3.62, up 44.80%, on 7,663 volume with 31 trades. The average volume for the last 3 months is 1,352 and the stock's 52-week low/high is $1.75/$12.00.

Thin Film Electronics ASA (TFECY)

QualityStocks, OTC Markets Group and MarketBeat reported beforehand on Thin Film Electronics ASA (TFECY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Thin Film Electronics ASA is an international leader in NFC (near field communication) mobile marketing solutions. The Company is enabling the Internet of Everything by way of its NFC solutions. Thin Film Electronics has its worldwide headquarters in Oslo, Norway; its U.S. headquarters in San Jose, California; and offices in Linköping, Sweden; San Francisco; London; Hamburg; Singapore; and Shanghai. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Thin Film Electronics’ mission is to deliver solutions that take advantage of mobile devices as intelligent agents to help create and connect the Internet of Everything. In addition, its mission is to create printed integrated systems utilizing unique, high-volume processes to deliver scale advantages over conventional electronics.

Thin Film Electronics provides consumer-centered NFC mobile marketing and industrial and supply chain solutions. These include blockchain applications. The Company provides end-to-end support throughout the whole process.

This begins with the manufacturing of NFC tags via its pioneering, roll-to-roll printed electronics production process, integration support to get the tags on physical objects, and the Company’s CNECT™ cloud-based software platform that captures data and provides actionable insights into consumer behavior and business logistics.

Thin Film Electronics creates printed tags, labels, and systems that include sensors and wireless communication. It offers end-to-end mobile marketing solutions. These solutions feature hardware, label/packaging integration services, and comprehensive cloud-based reporting and analytics.

The Company’s NFC Solutions are optimized for consumer and industrial applications. This includes its OpenSense™ Technology - Dual-ID tag with sealed/opened sensor. It features authentication and refill fraud protection. Its solutions also include SpeedTap™ Technology - Single-ID tag. It features instant product authentication and targeted marketing and track & trace capabilities.

Recently, Thin Film Electronics ASA announced a collaboration with Clause, the leading provider of “smart” legal contracting technology. Via this collaboration, Clause and Thin Film will use NFC to facilitate the pairing of physical goods to digital contracts through the tap of a smartphone.

The resulting connection will deliver important functional and efficiency improvements for customers across the Clause “connected contracting” platform. Thin Film Electronics will integrate Clause’s connected contracting solution with the CNECT™ Cloud Platform. This will make it available to existing and prospective customers interested in "smart" legal contracts.

Thin Film Electronics ASA (TFECY), closed Monday's trading session at $0.57, up 46.1538%, on 14,700 volume with 6 trades. The average volume for the last 3 months is 12,488 and the stock's 52-week low/high is $0.100000001/$0.805999994.

Aequus Pharmaceuticals, Inc. (AQSZF)

We are reporting on Aequus Pharmaceuticals, Inc. (AQSZF), here at the QualityStocks Daily Newsletter.

A specialty pharmaceutical company, Aequus Pharmaceuticals, Inc.’s focus is on developing, advancing, and promoting differentiated products. The Company’s development stage pipeline includes a number of products in neurology and psychiatry with the aim of addressing the need for improved medication adherence via enhanced delivery systems. OTCQB-listed, Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia.

The Company’s most recent addition to the development pipeline was a long-acting form of medical cannabis. Aequus’ intention is to commercialize its internal programs in Canada together with its present portfolio of marketed established medicines.

Aequus Pharmaceuticals will look to form strategic partnerships, which would maximize the reach of its product candidates globally. Its plan is to build on its Canadian commercial platform via the launch of more products that are either created internally or brought in via an acquisition or license.

Aequus has two preclinical programs now in formulation optimization, AQS-1302 and AQS-1303. AQS-1302 is being advanced for the potential treatment of epilepsy with a once-weekly transdermal application. This is to provide patients with steady-state delivery of their medication. The expectation is that this product will decrease their risk of experiencing breakthrough seizures.

AQS-1303 is in development for the management of Nausea and Vomiting of Pregnancy (NVP). The expectation is that it will provide consistent anti-emetic control. This is while eliminating the risk of missed doses because of emesis (vomiting).

Aequus’ partners include Supernus Pharmaceuticals, Inc., Corium International, Inc., and Transdermal Research Pharm Lab. The Company will continue to expand its commercial pipeline with high quality, differentiated products. These include patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas. Aequus is developing numerous products in neurology and psychiatry. The aim is addressing the need for improved medication adherence by way of enhanced delivery systems.

This past September, Aequus Pharmaceuticals announced positive results from an initial Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the combination of pyridoxine hydrochloride and doxylamine succinate (the active ingredients in Diclegis®/Diclectin®).

The single-dose cross-over comparative bioavailability study in comparison to the presently approved oral version, Diclegis®/Diclectin®, was successfully completed in nine healthy female volunteers. The results suggested that sustained delivery of therapeutic levels of the active ingredients via the skin over a multi-day period is possible with the present formulation. The formulation was well tolerated. No serious adverse events were reported.

Previously, Aequus Pharmaceuticals announced that the European Patent Office issued an intention to grant a European patent for AQS1301, Aequus' once-weekly transdermal patch containing aripiprazole. AQS1301 is in development for the treatment of certain psychiatric disorders.

The intention of AQS1301 is to provide patients with a long-acting dosing alternative, which is comfortable, convenient, and user-friendly in an effort to promote medication adherence. This is the eighth regional patent issued or granted for AQS1301, following the U.S., Russia, Mexico, Japan, China, Canada, and Australia.

Moreover, Aequus Pharmaceuticals continues to increase revenues from its Canadian commercial arm via the on-going promotion of Vistitan™ and Tacrolimus IR. Vistitan™ (bimatoprost 0.03%) is a treatment for the lessening of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Tacrolimus IR is the first to market, and currently the only available generic version of tacrolimus immediate release in Canada. This is a product used for the treatment and prevention of acute rejection following organ transplantation.

Aequus Pharmaceuticals, Inc. (AQSZF), closed Monday's trading session at $0.2265, up 33.9603%, on 241,363 volume with 46 trades. The average volume for the last 3 months is 54,429 and the stock's 52-week low/high is $0.045000001/$0.230000004.

Kirkland's Inc. (NASDAQ: KIRK)

SmarTrend Newsletters, MarketBeat, Zacks, Greenbackers, Daily Markets, TradersPro, The Street, Hot Shot Stocks, Market Intelligence Center Alert, Trading Concepts, StockMarketWatch, Trading Markets, The Wealth Report, Barchart, StreetInsider, Marketbeat.com, Investment House, Daily Trade Alert, TradingMarkets, QualityStocks, FNNO Newsletters, TraderPower, Global Equity Report, Penny Stock Explosion, ChartAdvisor, BUYINS.NET, Dubai Penny Stocks, InvestorPlace, InvestorsUnderground, Kiplinger Today, 24-7 Stock Alert, MicroCap Press, Schaeffer's, SmallCapInvestor.com, SmallCapNetwork, StreetAuthority Daily, The Online Investor, TopStockAnalysts, WStreet Market Commentary and MarketClub Analysis reported previously on Kirkland's Inc. (KIRK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Shares of Kirkland's Inc. (NASDAQ: KIRK) traded today at $30.47, eclipsing its 52-week high. So far today approximately 542,000 shares have been exchanged, as compared to an average 30-day volume of 819,000 shares.

Over the past year, Kirkland's Inc. has traded in a range of $0.56 to $30.47 and is now at $28.24, 4,943% above that low.

There is potential upside of 373.6% for shares of Kirkland's Inc. based on a current price of $28.24 and an average consensus analyst price target of $133.73.

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. Its stores provide various merchandise, including holiday decor, framed arts, furniture, ornamental wall decor, fragrance and accessories, mirrors, lamps, decorative accessories, textiles, housewares, gifts, artificial floral products, frames, clocks, and outdoor living items. Its stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Kirkland's Inc. (KIRK), closed Monday's trading session at $29.20, up 12.3077%, on 986,062 volume with 9,527 trades. The average volume for the last 3 months is 1,015,594 and the stock's 52-week low/high is $0.560000002/$30.50.

Asia Broadband (OTC: AABB)

Small Cap Firm and Journal Transcript reported previously on Asia Broadband Inc. (AABB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Asia Broadband (OTC: AABB)has announced that its management, including its Board of Directors, recently approved a stock dividend. According to the announcement, the restricted common share dividend will be distributed on the basis of one dividend share for every 50 shares owned to shareholders of record as of April 5, 2021. AABB also released information for shareholders and the investment community regarding communications with its professional service providers. AABB noted that its professional service providers (i.e., auditor, legal firm, token developer, etc.) have received numerous requests for information regarding the company.

While these private firms are working closely with AABB to provide essential services as the company grows, these entities are not providers of information to the public. The company noted that the only source and outlet of information for AABB is its new investor relations agency and growth partner, which has been engaged specifically to meet the requests and demands for more information regarding the company. Contact information for AABB’s new investor relations firm will be announced in the next several days. AABB noted that there has been a significant increase in interest in the company, particularly as a result of the development and upcoming release of the AABB Gold (“AABBG”) cryptocurrency token.

To view the full press releases, visit http://ibn.fm/oCe8Q and http://ibn.fm/x328E

Asia Broadband, through its wholly owned subsidiary Asia Metals Inc., is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets. The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia.

This vertical integration approach to sales transactions is the unique strength of AABB that differentiates the company and creates distinctive value for shareholders. AABB also is releasing a freshly minted mine-to-token, gold-backed cryptocurrency and expects to become a worldwide standard of exchange that is secured and trusted with gold backing, an outstanding quality relative to other cryptocurrencies. For more information about the company, please visit www.AsiaBroadbandInc.com.

Asia Broadband Inc. (AABB), closed Monday's trading session at $0.241, up 0.83682%, on 78,245,486 volume with 8,020 trades. The average volume for the last 3 months is 83,004,915 and the stock's 52-week low/high is $0.0013/$0.658999979.

The QualityStocks Company Corner

Healthy Extracts Inc. (HYEX)

The QualityStocks Daily Newsletter would like to spotlight Healthy Extracts Inc. (HYEX).

Grey Cloak Tech (OTCQB: GRCK) has announced that the company has officially changed its name to Healthy Extracts Inc. The company’s ticker will also change to OTCQB: HYEX. These changes are official today, March 1, 2021. The company is focused on the development of its proprietary natural plant-based formulations; the company is also committed to sales and distribution of cardiovascular and neuro products. To view the full press release, visit http://ibn.fm/mxTNT

Healthy Extracts Inc. (HYEX) Healthy Extracts Inc. (HYEX), through its growing portfolio of wholly owned subsidiaries, is engaged in the proprietary research and development of natural plant-based formulations, sales, and distribution of cardiovascular and neuro products. The company’s focus is to advance its market positions in the broader health industry through the unique assets and operations of its science-based BergaMet North America and Ultimate Brain Nutrients (“UBN”) subsidiaries and to offer better lifestyles through superior health technology.

BergaMet North America

BergaMet NA is engaged in the sale and distribution of a full line of proprietary product formulations derived from the rare Citrus Bergamot SuperFruit™ called “bergamot.” Bergamot is native to Southern Italy and is naturally sourced and uniquely loaded with various antioxidant polyphenols. Thanks to this composition, bergamot supports and promotes overall wellness specific to cholesterol, cardiovascular and metabolic health with no known side effects.

BergaMet NA is the only Citrus Bergamot SuperFruit™ heart health supplement backed by 17 clinical studies. The BergaMet brand supplement boasts the highest quality and concentration of polyphenols and flavonoids available anywhere in the world. It is also the only bergamot supplement approved by the prestigious Accademia del Bergamotto of Italy. BergaMet NA is the only company authorized to manufacture, distribute and sell these products in the United States, Canada and Mexico.

Consumers are including the Citrus Bergamot SuperFruit™ in their everyday personal health programs. The clinically proven antioxidant provides benefits to tens of thousands of people daily.

The company’s line of products can be found at www.bergametna.com, through Amazon, other online retailers and in doctors’ offices throughout the United States.

The BergaMet Advantage

BergaMet has been studied in 17 published clinical trials which reported results of lower LDL cholesterol, higher HDL cholesterol, lower triglycerides, lower blood pressure, lower blood glucose, increased arterial function, improved liver function and is effective as a complement to statin use.

Cardiovascular disease is the number one cause of death in the U.S. and worldwide, claiming nearly 18 million lives each year accounting for 31% of all global deaths. In the U.S., statins are one of the most commonly prescribed medicines for cardiovascular disease. The Centers for Disease Control estimates that 28% of American women and men over the age of 40 take a statin to lower the amount of cholesterol in the blood.

Taking aim at this market for cardiovascular care, BergaMet NA continues to advance the awareness of its medical-grade supplements and separate its formulation from competitors.

BergaMet NA products contain 47% BPF (bergamot polyphenolic fraction), while its closest competitors have only 38%. The company’s increased dosages (600-675mg vs 500mg) and 47% BPF are clinically proven to be more effective in improving heart health and metabolic syndrome.

BergaMet Citrus Bergamot SuperFruit™ supplements:

  • Support healthy immune systems with powerful antioxidants and proprietary formulations.
  • Reduce cholesterol and support healthy glucose and blood pressure levels.
  • Are fully organic, vegan-friendly and dairy, gluten, soy and GMO-free.
  • Contain five key unique flavonoids that make up the most powerful 47% BPF (bergamot polyphenolic fraction) in the world, providing superior results compared to their competitors.
  • Have been clinically shown to increase arterial elasticity while reducing arterial and muscle inflammation.

Ultimate Brain Nutrients

Healthy Extracts’ Ultimate Brain Nutrients (“UBN”) subsidiary is a science-based company that develops unique, plant-based superior health technology neuro-products that improve brain health, including memory, cognition, focus and neuro-energy.

UBN’s KETONOMICS® proprietary formulations – targeting brain activity, focus, headache and cognitive behavior — provide multiple intellectual property license opportunities for monetizing the company’s portfolio.

License opportunities include multiple beverage formats, individual products, proprietary mixtures and other food platforms.

UBN has five unique formulation patents – one issued and four pending – targeting brain activity, focus, headache and cognitive behavior.

The UBN Advantage

UBN’s all-natural, sugar-free and caffeine-free proprietary formulations are the result of 20 years of scientific research and are positioned to provide consumer neuro-products that are natural brain solutions. UBN has filed for approval to the U.S. Food and Drug Administration (FDA) to make a Qualified Health Claim for its migraine formulation, tapping into consumer demands for healthy beverages that contribute to brain health, overall well-being and performance.

Over 50 million Americans consume unhealthy energy shots and drinks each day, while the neuro/energy market generates over $10 billion per year in revenue. Within this growing market, UBN is advancing its position to meet rising consumer demand for healthy, science-based options. The company’s KETONOMICS® proprietary formulations have been proven to naturally elevate brain energy and function, including memory, cognition and focus.

UBN’s KETONOMICS® supplementation has also been studied in sports physiology, with specific regard to its potential benefits for competitive performance and endurance.

Healthy Extracts Executive Team

Kevin “Duke” Pitts, Director, President and Chief Operating Officer

  • Started and built from the ground up two multi-million-dollar businesses, one of which grew into a Top 100 retailers in the U.S.
  • Unique management skills led to the development of successful teams for 35 years
  • Pioneered direct marketing for a Fortune 200 company, creating a 20% increase in targeted incremental sales
  • Founded Einstein’s Hemp, which developed and brought to market one of the only odorless and tasteless water-soluble CBD products in the world
  • Developed and implemented digital/guerrilla marketing strategies for public and private companies focused on long-term brand position and acquisition efforts
  • Specialized in customer relationship management (CRM) tools for creating the best customer experiences
  • Worked in publicly traded industries for 10 years, overseeing up to $20 million in annual marketing budgets

William “Bill” Bossung, Director, Chief Financial Officer

  • 35 years of diverse experience in corporate finance, insurance and accounting
  • 20 years of experience with IPOs focusing on audits, FINRA and SEC regulations
  • Specializes in the formation of capital raising over $100 million, recently raising $12 million for Splash Beverage
  • Specializes in upgrading penny stocks companies to the NYSE or Nasdaq
  • Involved in 30+ companies transitioning from private to public identities
  • Founded several companies, including BCF Technology Inc., which sold to Vertafore; managing partner at Bishop Equity Partners LLC; director at Splash Beverage Group; and director of finance at Chadmoore Wireless, where he licensed channels to Nextel for $162 million

Bill Croyle, Director, Private Investor and Accomplished Senior Executive

  • More than 40 years of success in the IT, energy, manufacturing, telecommunications, venture capital and finance industries
  • Broad expertise includes negotiating mergers and acquisitions, as well as service and delivery contracts
  • Formerly was a founder, owner or executive of EnTX Group; Impact Legacy Partners; FB Oilfield Special Tools; and Western Energy Advisors

Dr. Gerald Haase, Chief Medical Officer

  • Clinical professor of surgery at the University of Colorado, School of Medicine
  • Actively involved in medical research and clinical trials for 35 years
  • Received U-10 grant funding from the National Institutes of Health cooperative group clinical trials program, as well as U.S. Congressional funding for Cooperative Research and Development Agreements with the Department of Defense and NASA
  • Was chairman of the Department of Pediatric Surgery at Children’s Hospital Colorado; consultant surgeon to the Department of the Army; vice-chairman of the Children’s Cancer Group, a cooperative research consortium of the National Cancer Institute; on the National Board of Directors of the American Cancer Society; a senior member of the Commission on Cancer of the American College of Surgeons; and a member of the editorial board of The Annals of Surgical Oncology
  • Has published 180 scientific papers and is the inventor or co-inventor of 12 issued U.S. patents for micronutrient and phytonutrient therapy, with five pending patents
  • Recipient of clinical research grants and contracts funded at a several million-dollar cumulative level
  • Is an editorial reviewer for medical journals and a member of numerous professional societies, including the American Association for Cancer Research, International College of Surgeons, American Academy of Pediatrics, New York Academy of Sciences and American College of Physician Executives

Healthy Extracts Inc. (HYEX), closed Monday's trading session at $0.052, even for the day, on 352,627 volume. The average volume for the last 3 months is 38,601 and the stock's 52-week low/high is $0.019999999/$0.109999999.

Recent News

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be hosting a conference call and webcast on Tuesday, March 9, 2021, ET. The purpose of the call is for the company to announce its fourth-quarter and fiscal year results. DRIO CEO Erez Raphael, president and general manager of North America Rick Anderson and CFO Zvi Ben-David will host the conference, which is scheduled to begin at 8:30 a.m. ET. To view the webcast, visit http://ibn.fm/oczM6. To view the full press release, visit http://ibn.fm/4u0wV.

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Monday's trading session at $27.17, up 2.1429%, on 163,727 volume with 1,804 trades. The average volume for the last 3 months is 183,869 and the stock's 52-week low/high is $3.01999998/$31.8500003.

Recent News

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has released a shareholder update outlining the company’s stable business development and remarkable performance throughout 2020, as well as several key business milestones that have set the course for what Foresight believes will be a successful year. In addition, the company today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., successfully completed a controlled trial of its Eye-Net(TM) Protect cellular-based accident prevention solution for the intelligent transport system division of a multi-billion-dollar global Japanese vehicle manufacturer. To view the full press releases, visit https://ibn.fm/FtBVW and https://ibn.fm/kh4Af

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Monday's trading session at $9.06, up 33.4315%, on 25,805,483 volume with 95,430 trades. The average volume for the last 3 months is 15,334,045 and the stock's 52-week low/high is $0.460999995/$12.1445999.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its Sequire SaaS platform, recently announced that its LD Micro subsidiary reconstituted its North American microcap index to reveal a 35.72% increase of 423 new listings for a total of 1,189 companies (https://ibn.fm/a7p3d).

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $4.58, up 25.4795%, on 1,330,825 volume with 6,258 trades. The average volume for the last 3 months is 704,011 and the stock's 52-week low/high is $1.50999999/$7.19500017.

Recent News

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF)

The QualityStocks Daily Newsletter would like to spotlight TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF).

TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2), a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco, announced plans to expand into Canada with its recently signed memorandum of understanding (“MOU”). The agreement with Christina Lake Cannabis Corp. (CSE: CLC) outlines a partnership between the two companies to develop and distribute TAAT(TM) for the Canadian market. To view the full press release, visit http://ibn.fm/dmNq7. Within the first five days of the launch of its e-commerce portal, TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) reported that its flagship product — TAAT(TM), a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol —had totaled more than CDN$100,000 in sales, with $48,000 of that coming in the first 48 hours (https://ibn.fm/cyc6O). Those numbers confirm what the TAAT team has known since the launch of the product only two months ago: legal-age smokers are eagerly looking for a nicotine- and tobacco-free smoking experience (https://ibn.fm/0mrwU).

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) is a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco.

The key players of TAAT Lifestyle & Wellness are from leading tobacco brands. They are guiding the mission with the company’s proprietary product, TAAT(TM), which uses the company’s proprietary Beyond Tobacco(TM) base material. The base material undergoes a 14-step process to taste and smell just like tobacco and uses a patent-pending refinement technique.

This provides the company with unique opportunities on the global tobacco market, which was estimated at $849 billion in 2019, with approximately 1.3 billion people using tobacco in some form worldwide (https://nnw.fm/bvKFL).

TAAT Lifestyle & Wellness was founded in 2006 and is headquartered in Vancouver, Canada, with operations in Las Vegas, Nevada.

TAAT(TM)

TAAT is a smokable alternative to tobacco cigarettes using the Beyond Tobacco base material, which contains zero tobacco and zero nicotine. The current TAAT offering comes in three varieties: Original, Smooth and Menthol, which were launched during Q4 2020 in Ohio. The company’s Ohio tobacco wholesaler also distributes for major tobacco industry names such as Altria, RJ Reynolds (a subsidiary of British American Tobacco) and ITG.

The TAAT Beyond Tobacco experience was created to replicate the sensory elements of smoking a tobacco cigarette. Market testing in California and Nevada reached a consensus that TAAT products offered no significant differences in experience when compared to tobacco cigarettes, in terms of the following aspects:

  • Visual – the nearly identical product packaging and enhanced smoke volume
  • Auditory – the “crackling” sound of the base material when it is ignited
  • Smell – when burning, TAAT emits a tobacco-like scent
  • Taste – the patent-pending Beyond Tobacco base material undergoes a refinement process that creates a tobacco-like taste
  • Touch – TAAT satisfies the “hand-to-mouth” fixation and motor habits, such as flicking ashes

TAAT Beyond Tobacco Targeting Current Smokers

TAAT Lifestyle & Wellness is currently targeting the market of legal-aged smokers with its proprietary product. The company aims “not to create a new problem, but to solve an existing one.” TAAT Lifestyle & Wellness offers a non-addictive alternative to tobacco, with several competitive advantages making it a promising option on the United States market, such as:

  • Price – TAAT can be offered at a lower price than competing products in the tobacco category, which adds to the propositioned value for current legal-aged smokers.
  • Experience – TAAT appeals to current smokers who wish to give up the tobacco and nicotine but keep the smoking experience they enjoy.
  • Branding/Packaging – TAAT is American-grown and American-made, with its Beyond Tobacco base material serving as a legacy to the combustible tobacco products.

The current alternatives to cigarette smoking do not offer a comparable experience. Previously marketed products, like vaping, proved difficult for some legal-aged smokers to adopt, as the experience was too different from traditional cigarettes.

Market Outlook

In 2016, the United States tobacco market was valued at over $100 billion, a number that’s expected to grow over the next decade (https://nnw.fm/yd8oP). In terms of volume, over 215 billion cigarettes were sold to roughly 34 million adults in the United States in 2018. These numbers represent almost 14% of the adult population. Of those, almost two-thirds smoked more than 15 cigarettes in one day. A standard pack is comprised of 20 cigarettes.

The company’s Beyond Tobacco, as a non-tobacco product, has a price-driven consumer advantage in many states. While state taxes on traditional cigarettes vary, most tend to average around $1.82 per pack. Washington D.C. is on the higher end of the tax spectrum at $4.50 per pack, whereas Missouri is only $0.17 per pack (https://nnw.fm/D3WnT).

TAAT Lifestyle & Wellness estimates that, if one pack of TAAT Beyond Tobacco was sold at 20% of all United States tobacco points of sale, the product would capture 0.25% of the market, the equivalent of approximately 2.7 million cartons of cigarettes per year.

Management Team

Setti Coscarella is the Chief Executive Officer of TAAT Lifestyle & Wellness Ltd. He is experienced in investment banking, private equity and entrepreneurship. In 2017, Mr. Coscarella was the lead strategist for Reduced-Risk Products at Philip Morris International. While there, he worked with thousands of smokers to better understand how to position smoking alternatives, developing programs that could help smokers convert to reduced-risk products. Mr. Coscarella holds an MBA from the Schulich School of Business, specializing in finance, marketing and corporate strategy. He also has a Bachelor of Science in mathematics and physics from the University of Toronto.

Tim Corkum is the company’s Chief Revenue Officer. He has a lengthy history in the tobacco industry, having served 21 years at Philip Morris International. Mr. Corkum has experience leading the international commercialization of combustible cigarettes and working on reduced-risk product offerings. During his 21-year tenure, he held senior positions in business development, sales strategy, key account management and corporate affairs. He holds a BA from Carleton University with a concentration in law.

Joe Deighan is Founder of TAAT Lifestyle & Wellness and oversees research and development. He is the founder of vape liquid ‘JJuice’, created in 2012. JJuice was distributed across all of the United States and in 26 other countries, alongside the private label production that was done for other brands. Mr. Deighan sold JJuice in a cash deal that was valued at over $800,000 in 2017. He currently handles all R&D and production for Beyond Tobacco, knowing the product better than anyone else in the company.

TAAT Lifestyle & Wellness Ltd. (TOBAF), closed Monday's trading session at $3.78, up 2.1622%, on 85,054 volume with 353 trades. The average volume for the last 3 months is 238,683 and the stock's 52-week low/high is $0.100000001/$4.73999977.

Recent News

Ideanomics Inc. (NASDAQ: IDEX)

The QualityStocks Daily Newsletter would like to spotlight Ideanomics Inc. (NASDAQ: IDEX).

Ideanomics Inc. (NASDAQ: IDEX) was highlighted today in a publication from PennyStocks.com, which writes “IDEX stock has been on our watch list for months at this point. In fact, over the last 12 months, the penny stock has climbed from under 40 cents to as high as $5.53 this year. Obviously, Ideanomics suffered the same sell-off that broader markets faced late last month.”

Ideanomics Inc. (NASDAQ: IDEX) is a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products. Ideanomics is currently divided into two divisions – mobility and capital. These divisions provide shareholders with access to disruptive and high-growth opportunities.

The company expects 2021 to be another growth year after it raised approximately $400 million over the past six months. This funding has already been put to good use with acquisitions of Wireless Advanced Vehicle Electrification (WAVE) and Timios. With roughly $200 million still on the balance sheet, Ideanomics continues to look for new investments and acquisitions in revenue-based opportunities focused on EV and fintech businesses.

Founded in 2004, Ideanomics is headquartered in New York, New York, with additional offices in Hangzhou, Beijing and Qingdao, China. Its current operations span the United States, China, Ukraine and Malaysia.

Ideanomics Mobility

Ideanomics Mobility is focused on the EV market. The global commercial EV market was valued at $34.7 billion in 2018 and is expected to grow at a CAGR of 39.9% through 2022 to reach a total of $132.73 billion (https://ibn.fm/pPrf4). According to a survey by Grand View Research, the global EV charging infrastructure market is also expected to grow and reach $144.97 billion in 2028, expanding at a CAGR of 33.4% from 2021 to 2028.

This growth is expected to be driven by increased support of electric vehicles from the public, as well as the current U.S. administration, which has a goal of achieving a 100% clean-energy economy.

The Ideanomics Mobility unit consists of five companies:

  • Mobile Energy Global (MEG) – Wholly owned China-based service provider of the Sales-to-Finance-to-Charging (S2F2C) business model to assist commercial fleet operators on EV enablement. Recent sales include 2,000 units of D1, BYD’s custom electric ride-hailing vehicle.
  • Medici Motor Works – Wholly owned North America division. MMW will develop zero-emissions specialty vehicles, trucks, buses and vans for the North American market.
  • Wireless Advanced Vehicle Electrification (WAVE) – Wholly owned Utah-based commercial EV charging technology company with a specialized offering of in-ground wireless charging for commercial vehicles. WAVE’s chargers power the Antelope Valley Transportation Authority, the largest municipal EV bus system in the country. Its revenue for 2020 exceeded $7 million, and it boasts a robust pipeline for 2021 and beyond.
  • Treeletrik – Majority investment in Malaysian-based OEM will service a high-demand market – electric delivery mopeds. Treeletrik has obtained certifications in Thailand and Indonesia, with orders secured for 2021. Its North American marketing program is expected to commence in 2021. As a part of the ESG initiative, one tree will be planted for every unit sold.
  • Solectrac – Minority investment in California-based electric tractor company. Solectrac manufactures 100% electric tractors to benefit farmers, crops and the planet at a time when the agriculture market remains virtually unaddressed by EV solutions.
  • Silk EV – Minority investment in hyper car and performance car design company, which provides access to the high-end battery and charging technology development ecosystem.

Ideanomics is generating EV revenue from its Sales to Financing to Charging (S2F2C) business model, which features three operating areas:

  1. Vehicle and Battery Sales: Medici, Treeletrik and Solectrac cover three key market segments
  2. Financing, Leasing and Insurance: Offering financial services to fleet customers, commission delivery and origination fee-based revenue
  3. Charging and Energy Services: Offering charging as a service, battery swap programs and WAVE wireless charging products

Ideanomics Capital

Ideanomics Capital is focused on providing disruptive fintech solutions across the entire board of financial services, ranging from financial markets to digital securities and assets to mortgages and more. More mainstream institutions and a growing number of companies have increased their digital securities services, along with institutional investments boosting bitcoin and the emergence of favorable regulatory developments, creating ample opportunities for widespread adoption of financial technologies.

Additionally, the U.S. real estate industry is ripe for technologization, as it currently is fragmented, antiquated, opaque and largely untouched by tech innovation. However, the expanding market, with U.S. home sales expected to grow 21.9% in 2021, and the increased digitization of all business spaces are expected to promote a digital-first experience as the new industry standard this year and beyond (https://ibn.fm/DwsUv).

The Ideanomics Capital unit consists of five companies:

  • Timios – Wholly owned subsidiary bringing real estate into the 21st century by providing value-add, fee-based services addressing the title and closing process of home buying and mortgage transactions. Timios works to create transparency and efficiency within the market. Timios ended 2020 as a cash flow and EBITDA positive business.
  • The Delaware Board of Trade (DBOT) – Wholly owned FINRA-regulated ATS and broker dealer based in Delaware.
  • Liquefy – Minority investment bringing innovation to investment in real assets with blockchain technology by increasing efficiency in fractional ownership, lowering entry to investment barriers and unlocking liquidity in assets that were previously illiquid.
  • Technology Metals Market (TM2) – Minority investment in UK company delivering a direct investment and trading market for technology metals with a newly accessible technology metals asset class for inventory diversification. The traded metals are 100% backed by physical metals.
  • Intelligenta – Investment providing AI and machine learning solutions for financial institutions and regulators.

Management Team

Alf Poor is Ideanomics’ Chief Executive Officer. He is a client-focused and profit-driven executive who has a track record of success in rapidly growing technology companies and large, multi-national organizations. Mr. Poor’s expertise includes business planning, financing and creating and implementing corporate governance policies, as well as handling management across organizations. His specialization is working with cross-border and multi-national startups. Before taking the CEO role at Ideanomics, he was the CEO for Global Data Sentinel.

Conor McCarthy is the company’s Chief Financial Officer. He is a strategic and operationally oriented management-level professional. His extensive international experience is within the fintech, data science and advertising technology sectors. Mr. McCarthy has experience with public companies, PE, and VC-backed firms. His specializations are financial and management reporting, planning and analysis, financial modelling, performance metrics, KPIs, venture borrowing, Series A equity funding, ERP system implementation, international business operations, and acquisition due diligence and integration. Before joining Ideanomics, Mr. McCarthy most recently held a CFO position at OS33. Prior to that, he was CFO for Intent Media Inc.

Kate Lam is the company’s Managing Director of Financial Products. She is highly regarded for her fixed income capital marketing skills across Asia and the United States. Ms. Lam has over 25 years of experience in the financial markets industry, dealing with many asset classes and clients. Having spent a few years in the fintech startup industry, her skills bridge the gap between traditional financial assets and new technological innovations. She has held senior management positions at Bear Sterns, Deutsche Bank and Standard Chartered Bank.

Keith Byers is Ideanomics’ Senior Vice President of Operations. He has extensive experience managing strategic relationships with key clients and deepening the relationships through innovation and successful engagement strategies. Before Ideanomics, Mr. Byers was the Managing Partner and Head of Operations for Gain Theory. He has a Master of Arts – MA, Economics from Heriot-Watt University and a Master of Science – Economics from The University of Edinburgh.

Tony Sklar is the company’s Senior Vice President of Investor Relations. He is a communication strategist and has worked for multi-faceted companies with global operations. Mr. Sklar handles omni-channel distribution using intelligence platforms and data insights for strategic planning, international expansion and marketing channels. His specialties include project management with digital strategy and transformation, ICO, marketing, blockchain and strategic partnerships. In addition to his role with Ideanomics, he is also a board member for the Delaware Board of Trade and the host and senior technology reporter for Far From TV.

Ideanomics Inc. (IDEX), closed Monday's trading session at $3.63, up 13.7931%, on 43,609,983 volume with 124,790 trades. The average volume for the last 3 months is 46,708,144 and the stock's 52-week low/high is $0.275999993/$5.5300002.

Recent News

Kaival Brands Innovations Group Inc. (KAVL)

The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).

Kaival Brands (OTCQB: KAVL), a company focused on generating stockholder value by incubating innovative products into mature and dominant brands, is the exclusive global distributor of all products manufactured by Bidi Vapor LLC. Bidi Vapor's primary offering, the Bidi(R) Stick, is the fastest-growing closed system vaping product in the U.S. and the only vape product on the market with an ecologically friendly, mass-recycling program. To view the full press release, visit http://ibn.fm/6jSIp

Kaival Brands Innovations Group Inc. (KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.

Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.

Bidi™ Stick – Revolutionizing the Vaping Experience

On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.

Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.

Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.

On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.

On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.

“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (http://nnw.fm/unAyG).

Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.

Partnership Impact and Market Outlook

Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.

The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (http://nnw.fm/44sq4).

The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.

Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.

To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.

Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.

Cancellation of 300 Million Shares of Common Stock

In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock (http://nnw.fm/W7s9T). Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.

According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.

Management Team

Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

Kaival Brands Innovations Group Inc. (KAVL), closed Monday's trading session at $2.85, up 5.5556%, on 244,703 volume with 316 trades. The average volume for the last 3 months is 593,673 and the stock's 52-week low/high is $0.016/$3.65000009.

Recent News

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER)

The QualityStocks Daily Newsletter would like to spotlight The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER).

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) was featured today in the 420 with CNW by CannabisNewsWire. Marijuana has been used for many centuries as an aphrodisiac, with early recordings showing its use in India in the seventh century. Presently, many consumers of marijuana claim that the substance improves one’s sex life. At the same time, others claim that marijuana can also affect sex negatively in different ways. However, science has shown that cannabis can improve an individual’s sex life in various ways. We look at them below.

Founded in 2012, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked label ‘Clean Beverage’. Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 Infused™ in 2019 to meet consumer demand for flavor-infused products. A88 Infused™ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBD™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Innovation and Expansion

Founded in 2012, The Alkaline Water Company began with a mission to create the best-tasting water in the world. At the time, there were two emerging trends in health-conscious consumers: a growing interest in the alkaline diet and perceived health benefits of pink Himalayan rock salt. By combining these two concepts in an alkaline water and trademarking the name Alkaline88, The Alkaline Water Company began offering what it calls the smoothest tasting Clean Beverage™ in the U.S. enhanced-water category.

Now a top bulk alkaline-water brand (the company reported record sales in March and April 2020, surpassing March and April 2019 numbers by 114% and 171%, respectively), The Alkaline Water Company is committed to growing its national footprint through innovation and expansion. That mindset was evident as the company introduced eco-friendly aluminum bottles and branched out into flavor-infused waters; the company currently offers six different flavors: peach/mango, lemon/lime, raspberry, watermelon, blood orange and lemon.

The company’s commitment to innovation may be most evident in its newest product line: A88CBD. This line of CBD-infused products includes tinctures, capsules, gummies, salves, balms, hand and foot lotions, essential oils, bath bombs and bath salts, as well as CBD-infused drinks, water and beverage shots. These quality, CBD-infused offerings are all made with lab-tested, full-spectrum hemp and are conveniently packaged and perfect for on-the-go or at home use.

In addition, The Alkaline Water Company has implemented an aggressive growth strategy, with numerous organic initiatives focused on national multichannel, mass-market expansion through a direct-to-warehouse model and co-packing facilities that are strategically located within 600 miles of 95% of the U.S. population. In addition to this strong brick-and-mortar approach, the company recently launched a B2C e-commerce platform (www.A88CBD.com) and aggressive digital-marketing campaigns.

Clear Advantages in a Growing Market

With consistent growth year over year, the company reported $32.2 million in revenue in fiscal 2019 and has emerged as a growth leader in the functional (value-added) waters space, which is the fastest-growing segment of the bottled water industry.

The Alkaline Water Company’s efforts are focused on its clear competitive advantages, including its strong marketing (the inclusion of alkaline in product names); existing grocery channels, which feature excellent relationships and a nationwide broker network; distinctive branding; proprietary technology, which produces great-tasting, high-quality water, infused drinks and other products; and price, with a broad range of products in all formats, from bulk bottles to single serve.

As the company focuses on strategic growth, it is eyeing the impressive potential of a market that is on a strong upswing. Annual bottled water sales have now surpassed soda consumption, with soda sales in the United States having declined by $1.2 billion over the past five years. Some research indicates that the global bottled water market will reach an estimated $280 billion this year, while the CBD market is forecast to top $20 billion by 2024.

With its products available in all major trade channels, including grocery stores, drug stores, c-stores and big-box retailers, The Alkaline Water Company is also looking to expand into new spaces, such as health and beauty, hospitality and specialty retailer locations.

Seasoned Management Team

The Alkaline Water Company is led by an experienced team focused on the company’s core strategy of building a national retail footprint and extending its lifestyle brands into other consumer packaged goods categories.

Richard A. Wright, President, CEO and Co-Founder of The Alkaline Water Company Inc., oversees all aspects of the business, successfully guiding the company through strategic opportunities and delivering greater than 50% growth since the company’s inception. A passionate and versatile leader with a strong track record of innovation, collaboration and achieving goal-driven results, Wright is a serial entrepreneur with more than 41 years of experience. Early in his career, he spent years at one of the ‘Big Four’ accounting firms, working his way up to Regional Director of Tax and Financial Planning. As a CPA, entrepreneur and former CFO, Wright brings extensive knowledge of finance, operations, sales and marketing to the team, and he has participated in hundreds of M&A transactions throughout his career.

David Guarino, CFO, Secretary, Treasurer and Director, earned a Bachelor of Science in accounting and a Master of Accountancy from the University of Denver. From 2008 to 2013, Guarino was President and a Director of Kahala Corp., a worldwide franchisor of multiple quick-service restaurant brands with locations in 49 states and more than 25 countries. From 2014 to 2015, Guarino was President of HTI International Holdings Inc., a technology company focused on forward osmosis water filtration technology.

Frank Chessman, National Sales Manager, is a graduate of the University of Southern California’s Marshall School of Business. He spent 25 years with Ralph’s Grocery, Kroger’s largest division, working at many levels before ultimately becoming Vice President of Advertising & Marketing. He then served 14 years as Executive Vice President at Simon Marketing. Chessman has more than a decade of experience in the beverage manufacturing industry.

Brian Sudano, Director, is managing partner of Beverage Marketing Corporation and BMC Strategic Associates. Sudano’s experience covers nearly the entire beverage industry, from energy drinks to wine, with special expertise in beverage alcohol by virtue of varied industry experience across a broad range of projects. Sudano manages several major clients, providing ongoing strategic and market advice and leading projects in strategic planning, market entry analysis and planning, sales/distribution, business modeling, brand repositioning and international opportunity assessment. He has spoken at many beverage industry events and is a contributing editor at Beverage World magazine.

Aaron Keay, Chairman, has been a successful investor, entrepreneur and financier to multiple small cap and startup companies over the last decade. During his time with these companies, he served in advisor, board-member and senior-management roles. His experience ranges across multiple sectors in mining, biotech, health and wellness, tech and cannabis, where he has invested and raised more than $500 million.

The Alkaline Water Company Inc. (NASDAQ: WTER), closed Monday's trading session at $1.22, up 6.087%, on 759,885 volume with 2,140 trades. The average volume for the last 3 months is 2,312,538 and the stock's 52-week low/high is $0.400000005/$2.5999999.

Recent News

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)

The QualityStocks Daily Newsletter would like to spotlight PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF).

PlantX Life (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has released results of its recent annual and special shareholder meeting. The meeting was held Feb. 26, 2021, and during the meeting, shareholders nominated and elected five board members: Quinn Field-Dyte, Lorne Rapkin, Peter Simeon, Alex Hoffman and Ralph Moxness. The company noted that incumbent director Todd Shapiro did not seek re-election at the meeting. To view the full press release, visit: https://ibn.fm/S9UF2

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more.

PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including:

  • An easy-to-use e-commerce shopping experience featuring the following:
    • Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
    • Meal delivery with recipes created by well-known plant-based chefs throughout the world
    • Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
    • Easy to follow plant-based recipes every week
    • Partnerships with restaurants, nutritionists, chefs and brands
    • A community of like-minded individuals
  • State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home.

Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community.

The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). The company’s common shares are eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States.

Market Outlook

With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020.

Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%.

PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries.

Digital Platform for the Plant-Based Community

The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings.

PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

  • Shop
  • Find recipes
  • Read blogs
  • Join a community forum
  • Listen to podcasts
  • View cosmetics
  • Research vitamins
  • Purchase plant-based pet foods
  • Read corporate updates
  • Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine.

PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel

PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition.

These PlantX branded flagship locations will first launch in:

Customer engagement, education and creating a global plant-based community will be furthered through this initiative.

PlantX Restaurant Partnerships

With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier.

PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus.

Future Goals for PlantX Life

Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel.

Verticals launched in 2020 include:

  • New meals and programs by renowned chefs
  • Flagship PlantX locations
  • PlantX branded goods
  • United States meal delivery and LIV
  • Online peer-to-peer fitness

Management Team

Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk.

Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles.

Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception.

Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), closed Monday's trading session at $0.93, up 5.1798%, on 100,864 volume with 221 trades. The average volume for the last 3 months is 278,069 and the stock's 52-week low/high is $0.349999994/$1.85000002.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global (OTCQB: SHRG) has announced that Document Security Systems (NYSE American: DSS) has increased its investment in SHRG through an additional $30 million convertible promissory note. SHRG is a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling industry. To view the full press release, visit http://ibn.fm/fxqzB

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.372105, up 56.3466%, on 2,655,278 volume with 568 trades. The average volume for the last 3 months is 156,529 and the stock's 52-week low/high is $0.027/$0.730000019.

Recent News

Grapefruit USA Inc. (OTCQB: GPFT)

The QualityStocks Daily Newsletter would like to spotlight Grapefruit USA Inc. (OTCQB: GPFT).

Grapefruit USA (OTCQB:GPFT), a premiere, fully licensed California-based cannabis company, is providing an update regarding the announcement of a potential acquisition transaction. The company earlier announced that a Canadian cannabis company had shown interest in entering  discussions involving an acquisition transaction; those discussions led to the two companies signing a memorandum of understanding (“MOU”) in February. The MOU outlines terms under which the parties could enter into a joint venture (“JV”) that would call for the joint manufacture, distribution and marketing in Canada of Grapefruit’s products, including but not limited to Grapefruit’s flagship Hourglass(TM) THC/cannabinoid time-release delivery cream. To view the full press release, visit: https://cnw.fm/7u5PN

Grapefruit USA Inc. (OTCQB: GPFT) is a Delaware corporation that is a fully licensed premier cannabis manufacturer and distributor in the legal cannabis marketplace with its own patented and branded line of products.

The company manufactures its patented product line and distributes it, along with other cannabis products, to all properly licensed cannabis product businesses.

Grapefruit is the only cannabis company that has harnessed cutting edge science and technology to bring patented, truly disruptive products to the medicinal and recreational cannabis marketplace, fundamentally changing the way individuals use THC, CBDs and hemp-derived CBDs and capitalizing on the rise in demand for these unique products.

Headquartered in Los Angeles, California, the company has held licensing in the state for manufacturing and distributing cannabis since 2018. Grapefruit currently owns and operates a California-licensed cannabis extraction laboratory and a licensed wholesale distribution facility in the Coachillin’ Canna-Business Park near Palm Springs, California. Grapefruit is managed by a team of experts who possess the experience, skills and resources required to succeed in the competitive cannabis marketplace.

Hourglass™ Topical Delivery Cream

Grapefruit’s patented Hourglass™ topical delivery cream has solved the previously insurmountable difficulties of efficient skin absorption of THC and other cannabinoids.

Hourglass™ allows users to experience a sustained and holistic delivery of THC/cannabinoids providing “the entourage effect” following initial application to the skin. Additional applications may be made confidently and discreetly at the user’s discretion. There simply is no other product on the planet which successfully utilizes a patented time release THC and CBD delivery mechanism to deliver the holistic benefits of cannabis to those who need it.*

Hourglass™ is a unique, highly concentrated full spectrum time-release topical delivery cream that releases a holistic amount of THC, along with a wide range of cannabinoids (or just CBD), over a four- to eight-hour period.* The formula then comes off through the natural sloughing process of dead skin cells. Hourglass provides many holistic benefits, all of which promote health and wellness as it’s number one goal.

Hourglass™ provides users with an entourage effect of THC plus a wide range of cannabinoids, including CBD, Cannabinol (CBN), Cannabigerol (CBG), Delta-8, Tetrahydrocannabivarin (THCV), and Cannabielsoin (CBE) in a Patchless Patch™ system that is novel and proprietary to the company.

Hourglass™ Topical Delivery Cream has fundamentally changed the way individuals use THC and cannabinoids to obtain their holistic benefits.* As a result, smoking cannabis or hemp flowers and orally consuming edibles, which are metabolized in the gut and liver resulting in uneven reactions, are no longer the exclusive ways to receive both the medicinal and recreational benefits of THC/cannabinoids.* Now for the first time in history, there is an effective, easy to use third choice – Hourglass™ by Grapefruit.

*This product is not regulated by the FDA and is not intended to cure, mitigate, treat or prevent disease.

Grapefruit Cannabis Services

Grapefruit distributes cannabis flower and cannabis products, including its own proprietary products, as well as a wide range of services, to other properly licensed cannabis product businesses. These products and services include:

  • Distribution – As a premier licensed distributor, Grapefruit handles the distribution of all-things cannabis throughout California, specializing in bulk AAA exotic indoor flowers sourced from farms located in the state. The wholesale distribution arm facilitates flowers, fresh and dry frozen, and oil transactions in bulk wholesale form. Its wholesale distribution arm distributes its patented Hourglass™ topical delivery cream.
  • Manufacturing – The company owns and operates a fully licensed and compliant ethanol extraction lab that produces a high-quality distillate. This THC Honey Oil distillate is a universal product used in everything, including infused edibles, tinctures, creams and even vape cartridges. Its patented Hourglass™ cream is also manufactured exclusively at Grapefruit’s Coachillin lab facility by highly trained Grapefruit personnel.
  • Hourglass™ Topical THC+CBD Delivery Cream – The company’s patented Hourglass™ Topical Delivery Cream has solved the inherent difficulties of efficient skin absorption of THC and cannabinoids such as CBD, CBN, CBG and CBC, as well as hemp-derived CBDs and cannabinoids. Hourglass™ is a truly novel and disruptive delivery technology which fundamentally changes the way individuals will use THC and CBD to obtain their holistic benefits.*
  • Rainbow Dreams – Rainbow Dreams is the company’s lifestyle brand designed for the recreational cannabis marketplace. The brand captures the party-mode of the 1970s and offers vape carts with unique cannabis strains and natural flavors. The product fulfills an important marketplace niche – a top-shelf product that is competitively priced.

Market Outlook

The global cannabis market was valued at $10.6 billion in 2018. During the forecast period from 2019 to 2026, the market is expected to grow at a CAGR of 32.92%, reaching a projected value of $97.35 billion by the end of 2026 (https://nnw.fm/eTMSX).

Cannabis legalization has been gaining momentum around the world. Grapefruit is currently in a position to disrupt the industry – both the medicinal and recreational sectors – with proprietary products and manufacturing processes that harness the power of cutting-edge science and technology.

Management Team

Bradley J. Yourist is the Chief Executive Officer of Grapefruit. Mr. Yourist has been a follower of the medical cannabis market since the late 1990s, which allows him to understand the distribution model and the legal issues facing the market. He has also seen the benefit of cannabinoids in the medical industry. He understands the planning and operations of Grapefruit’s cannabis distribution arm and extraction lab and was instrumental in the planning for the facility.

Daniel J. Yourist is the Chief Operating Officer of Grapefruit. He is a licensed attorney in the state of California and a Real Estate Broker. Mr. Yourist is a licensing expert in the cannabis space and has gained extensive experience in all areas of managing a cannabis business in California. He ensures that every aspect of the company is run in accordance with state and local cannabis laws and regulations.

Grapefruit USA Inc. (OTCQB: GPFT), closed Monday's trading session at $0.15, up 11.0289%, on 3,226,588 volume with 622 trades. The average volume for the last 3 months is 1,845,250 and the stock's 52-week low/high is $0.013624999/$0.310000002.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

After years of stagnation, industry leaders are confident that the uranium market is going through a revival, heading for potentially rapid growth in the coming years. As a leading U.S. uranium producer, Energy Fuels (NYSE American: UUUU) (TSX: EFR) appears poised to seize on the growing calls for nuclear energy to be deployed to help address climate change and reduce air pollution. Also today, MiningNewsWire released a report on the company detailing how, from whatever angle you look at it, mining minerals from a sea bed offers unique benefits, not only because of economics buts also because of social justice issues and the environment.

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

Energy Fuels Inc. (UUUU), closed Monday's trading session at $5.19, even for the day, on 3,088,459 volume with 14,480 trades. The average volume for the last 3 months is 5,172,949 and the stock's 52-week low/high is $0.779999971/$6.4499998.

Recent News

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

The QualityStocks Daily Newsletter would like to spotlight XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has provided an update to its Jan. 22, 2021, press release regarding recent promotional and investor relations. The updated comments were made at the request of IIROC and the Canadian Securities Exchange ("CSE"). To view the full press release, visit: https://ibn.fm/UaAJn. Also today, the company was featured in a publication from PsychedelicNewsWire, examining how legislators in Vermont are planning to introduce no fewer than two measures to decriminalize drug possession this legislative session.

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. This includes products that are being readied for commercialization within the coming weeks, such as a rapid COVID-19 PCR test kit that reduces turnaround times to less than 30 minutes.

The company has research and development operations in North America and Europe and an operational focus in Germany. Its regulatory approval and commercialization focus is currently on products for the European market.

XPhyto was founded in 2017 and is headquartered in Vancouver, British Columbia.

Business Strategy & Milestones for 2021

On January 18, 2021, XPhyto issued a news release detailing its business strategy for the coming year. The company noted that it is “on the cusp of transformational change as product development programs advance from the laboratory to the clinic.” In addition to continuing to leverage its scientific expertise and operations in North America and Europe for product development and optimization, XPhyto intends to pursue growth through the commercialization of existing products and adherence to a focused investment strategy targeting impact-driven innovation with “the potential for extreme value creation.”

In particular, XPhyto is well positioned to execute on opportunities across its current business divisions, including:

  • Commercialization of infectious disease diagnostics
  • Clinical validation of transdermal and sublingual drug formulations
  • Continued investment and development in psychedelic medicine

“2020 was a very productive year for XPhyto. We made significant progress in all areas of our business,” Hugh Rogers, CEO & Director of XPhyto, stated in the update. “We have ambitious milestones for 2021 with multiple product launches on the horizon, multiple clinical drug programs underway, and an aggressive commitment to psychedelic medicine. I am extremely confident that our team can execute on the company’s business plan for 2021.”

Infectious Disease Diagnostics

XPhyto’s lead diagnostic product, secured through an exclusive global commercialization agreement with 3a-diagnostics GmbH (“3a”), is a rapid and highly portable PCR diagnostic test. Notably, PCR testing “has emerged as the only internationally recognized standard for COVID-19 testing” and is expected to play a key role in facilitating the recovery of the domestic and international travel industries, among others.

Successful validation of the PCR system was achieved in Q4 2020, and XPhyto has expressed confidence that it will achieve European commercial (CE-IVD) approval in Q1 2021. In preparation for this milestone and an anticipated Q1 product launch, the company is currently in discussion with manufacturing and distribution partners in Europe and the Middle East.

In addition to COVID-19 products, XPhyto and partner 3a are developing and commercializing a portfolio of low-cost oral biosensors. The company’s lead biosensor product is an oral health screening test for the detection of peri-implantitis for which XPhyto is targeting a late 2021 European commercial approval.

XPhyto does not make any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic.

Drug Formulation & Delivery

In 2020, XPhyto’s German subsidiary, Vektor Pharma TF GmbH (“Vektor”), reported significant advancement in four therapeutic programs targeting neurological indications with significant market demand. Vektor also successfully developed a sublingual drug formulation on contract for a major generic drug manufacturer and distributor.

XPhyto will look to build on this progress in 2021, with plans to complete human pilot studies evaluating its four lead therapeutic products:

  • Rotigotine transdermal patch for Parkinson’s disease
  • CBD oral/sublingual strip for treatment resistant epilepsy
  • THC oral/sublingual strip for anorexia/nausea
  • CBD:THC (1:1) oral/sublingual strip for multiple sclerosis associated spasticity

Per its 2021 business update, the company is currently in “ongoing discussions with multiple potential commercial partners, licensors and distributors and will be reviewing monetization opportunities on a continued basis.”

Psychedelic Medicine

Psychedelic compounds are a highly promising new class of active pharmaceutical ingredient (“API”) demonstrating strong potential for a variety of mental health conditions. XPhyto is positioned to capitalize on this promise through two strategic initiatives:

  • An agreement for the development of industrial scale biotechnology processes for the production of psilocybin
  • An agreement for R&D related to multiple psychedelic compounds, including psilocybin, mescaline, LSD, MDMA and DMT, among others

XPhyto intends to advance and expand its programs focused on the industrial scale production of psychedelic API in 2021. The company also plans to launch new programs for the development of psychedelic drug formulations, with a focus on sublingual and transdermal therapeutics and the integration of these products into established clinical programs relating to mental health indications.

Management Team

Hugh Rogers is the CEO and Director of XPhyto Therapeutics Corp. He is an entrepreneur and lawyer with private and public start-up company experience in various industries and operational roles. His recent advisory work has focused on public listings and corporate restructuring. This restructuring has occurred in the life science (cell therapy and medical device) and natural resources (natural gas co-gen and conventional oil) industries. Mr. Rogers holds a bachelor’s degree in Cellular Biology and Genetics and a law degree. He is a member in good standing of the Law Society of British Colombia.

Christopher Ross is the CFO of XPhyto. He is a professional accountant with broad financial experience across numerous industries, including forestry, distribution, construction, mining and multi-family real estate. He has provided advisory services to private and public companies in the areas of financial accounting, strategic analysis, audit and taxation. Mr. Ross holds a bachelor’s degree in commerce. He is a member in good standing with the Chartered Professional Accountants Association of British Columbia.

Wolfgang Probst serves as Director of XPhyto and Managing Director of BUNKER Pflanzenextrakte GmbH. He is a seasoned management and financial consultant based in Bavaria, Germany. He has consulting experience as branch head working with private clients and corporations of high net worth. In 2017, Mr. Probst assumed the CFO role of BUNKER and continues to play a key role in its operational and financial development.

Professor Dr. Raimar Löbenberg serves as Director of XPhyto. He holds a Bachelor of Science in pharmacy from Johannes Gutenberg-University and a Ph.D. in pharmaceutics from the Johann Wolfgang Goethe-University. He is the co-founder of RS Therapeutics Inc., which concentrates on foam-based topical drug delivery systems.

Professor Dr. Thomas Beckert is the Founder and Managing Director of Vektor Pharma TF GmbH. His expertise includes the formulation and machine development of transdermal therapeutic systems and ODFs. Professor Beckert holds a Bachelor of Science in pharmacy from the University of Freiburg and a Ph.D. in pharmacy and economics from the University of Tubingen.

XPhyto Therapeutics Corp. (OTCQB: XPHYF), closed Monday's trading session at $2.20, off by 9.8361%, on 134,522 volume with 371 trades. The average volume for the last 3 months is 67,939 and the stock's 52-week low/high is $1.3125/$3.0999999.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its plans to participate in two virtual investor conferences in the month of March. These include the Sachs 14th Annual European Life Sciences CEO Forum taking place March 10-12, as well as the 33rd Annual Roth Conference scheduled to be held from March 15-17, 2021. The company’s president and CEO, Rodney Varner, will lead Genprex’s presentations and will be available for one-on-one meetings with investors throughout the conferences. Interested parties should visit https://ibn.fm/MUouk and https://ibn.fm/J1qLh to register. The presentations will be available for replay on the company's website for a period of time following the events. To view the full press release, visit http://ibn.fm/K4xDf

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Monday's trading session at $5.38, up 4.2636%, on 1,008,450 volume with 5,321 trades. The average volume for the last 3 months is 1,842,079 and the stock's 52-week low/high is $1.49/$7.71999979.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Monday's trading